Home › Trial NCT03713905
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
- Trial IDNCT03713905
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorGuangzhou Gloria Biosciences Co., Ltd.
- Enrollment293
- Start date2017-07-01
- ConditionsAdvanced Solid Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.